• Study Resource
  • Explore
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
ORGANIC VOLATILE IMPURITIES AND THEIR REGULATORY LIMITS ( AS A PART OF PREFORMULATION)
ORGANIC VOLATILE IMPURITIES AND THEIR REGULATORY LIMITS ( AS A PART OF PREFORMULATION)

... If only Class 3 solvents are present, a nonspecific method such as loss on drying may be used. Solvents are used frequently to dissolve film-coating material to facilitate application onto compressed tablets. These tablets are subjected to air drying to remove all organic solvents from coat of finis ...
Hatch-Waxman Turns 30 - Yale Law School Legal Scholarship
Hatch-Waxman Turns 30 - Yale Law School Legal Scholarship

... described as adequate and well-controlled investigations providing efficacy and safety data sufficient for approval. Pursuant to the FDCA, the submission of a New Drug Application (NDA) was the final step following a successful clinical trial process. An NDA demonstrated the clinical circumstances i ...
Therapeutic options and challenges for substances of abuse
Therapeutic options and challenges for substances of abuse

... Study with over 600 subjects found, however, that disulfiram may be effective in patients with no major comorbid psychiatric disorder and who were motivated for abstinence.64 More recently, an evaluation of subjects with current depression on disulfiram reported lower craving over time than subjects ...
Essay Code D17 Heroin - Needles, Pain, and Addiction "[Users] just
Essay Code D17 Heroin - Needles, Pain, and Addiction "[Users] just

... effects of stress. Opioids, including heroin, share many psychoactive symptoms that vary in degree between each specific substance. Most importantly, opioids are analgesics, which raises pain thresholds, making users feel more comfortable when inflicted with continuous dull pain, common in cancer pa ...
Haldol/Haldol Decanoate (haloperidol)
Haldol/Haldol Decanoate (haloperidol)

... an older class of antipsychotics that have been the standard for treating psychotic disorders for many decades. When compared with a newer class of second-generation antipsychotics, these earlier antipsychotics are referred to as typical or conventional because they lack the wider spectrum of therap ...
Bioburden Control of Non-sterile Drug Substances and Products
Bioburden Control of Non-sterile Drug Substances and Products

... • Any environmental monitoring program would be  risk based in terms of sample selection and risk‐based in terms of sample selection and  frequency and would be used to confirm microbial  control and would not be linked to product release. control and would not be linked to product release. August 4 ...
In Vitro Metabolism of Quinidine: The (3S)-3
In Vitro Metabolism of Quinidine: The (3S)-3

... overexpressing the yeast reductase, whereas the latter expressed the human reductase. Culture media, selection, growth, harvesting, and preparation of microsomes have previously been described by Cullin and Pompon (1988) and Urban et al. (1990). Incubation Conditions. Microsomes were incubated in a ...
Vol 10, Issue 2 - Utah Poison Control Center
Vol 10, Issue 2 - Utah Poison Control Center

... No difference was seen in mortality or in any other outcome measure. The majority of patients in this study received the first dose of activated charcoal greater than two hours after ingestion which may have limited the efficacy of activated charcoal. ...
Drug delivery to the central nervous system: a review.
Drug delivery to the central nervous system: a review.

... Intracranial drug delivery is even more challenging when the target is a CNS tumor. The presence of the BBB in the microvasculature of CNS tumors has clinical consequences. For example, even when primary and secondary systemic tumors respond to chemotherapeutic agents delivered via the cardiovascula ...
Dosage Calculations INTRODUCTION
Dosage Calculations INTRODUCTION

EXAMINATION OF POPULATION GENETICS AND HARDY
EXAMINATION OF POPULATION GENETICS AND HARDY

... to the way two alleles interact with one another. Alleles can be either dominant or recessive. In the case of the allele possibilities G or g, we can refer to G as the dominant allele and g as the recessive allele. Complete dominance occurs if one allele in the heterozygous genotype (Gg) completely ...
Chronobiology and Chronotherapeutics – Possible Strategy for
Chronobiology and Chronotherapeutics – Possible Strategy for

... The following is a Brief Summary. For complete prescribing information, see package insert. INDICATIONS AND USAGE: Verelan® PM is indicated for the management of essential hypertension. CONTRAINDICATIONS: Verapamil is contraindicated in: 1. Severe left ventricular dysfunction (See WARNINGS). 2. Hypo ...
- Genetics
- Genetics

... A growing body of evidence suggests that loci with SA alleles exist in the genomes of various organisms (reviewed by Mank et al. 2008; Bonduriansky and Chenoweth 2009; Delcourt et al. 2009; Stulp et al. 2012). However, the only known SA polymorphisms are in fish, where male characters involved in att ...
Managing Osteoarthritis With Nutritional Supplements Containing
Managing Osteoarthritis With Nutritional Supplements Containing

... There is no cure for OA; therefore, once an individual is diagnosed, managing OA becomes a lifelong process. Although a physician initially diagnoses OA, pharmacists are the most accessible health care professional and play an integral role in managing each patient’s joint discomfort by dispensing p ...
Quantitative genetics of feeding behavior in two ecological
Quantitative genetics of feeding behavior in two ecological

... (QTL) analysis of key feeding behaviors. For each character in each environment, Castle–Wright’s estimator for the number of effective factors segregating ranged from 0.11 to 2.54. Similarly, between 0 and 3 QTLs were detected. In one case, a single QTL explained over 50% of the variance in the F2, ...
Bulletin #115
Bulletin #115

... 2) Satisfy New York diagnostic criteria: a score > 4 on the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) AND a score of > 4 cm on the 0-10cm spinal pain VAS on two occasions at least 12 weeks apart without any change of treatment. AND 3) Adequate response to treatment assessed at 12 w ...
Attention Deficit Hyperactivity Disorder (ADHD) Evaluating Prescription Drugs Used to Treat:
Attention Deficit Hyperactivity Disorder (ADHD) Evaluating Prescription Drugs Used to Treat:

... These medicines don’t cure ADHD but they can keep symptoms, such as hyperactivity and impulsivity, under control, which may improve a person’s daily functioning. However, there is no good evidence showing that these benefits last for longer than two years, so you may want to periodically discuss wit ...
Ephedra - Living Heart Foundation
Ephedra - Living Heart Foundation

... Education Council has questioned the FDA’s conclusions and claims the occurrence of adverse events and even deaths with those using ephedra is no higher than the “background level” that would be seen in a group of people of this size. In a few small studies, including those published from Harvard an ...
roxithromycin - ResearchGate
roxithromycin - ResearchGate

... daily for 10 days. Children: Usual doses are 2.5 to 5 mg/kg every 12 hours for 10 days.  C. PHARMACOKINETICS: Roxithromycin is rapidly absorbed; peak serum levels occur 2 hours after administration. Penetrates well into most body fluids and tissues except into saliva and CNS (in the absence of meni ...
booklet internal pages
booklet internal pages

... Background: The application of external physical stimuli to elicit site-specific cytotoxicity and/or enhance the cellular uptake of drugs offers significant potential in cancer therapy. Near-infrared light (NIR) as a stimulus provides deep tissue penetration with minimal effect on tissues. Indocyani ...
Current Antifibrinolytic Therapy for Coronary Artery Revascularization
Current Antifibrinolytic Therapy for Coronary Artery Revascularization

... and patients treated with aprotinin had a higher propensity for multiple morbidities than did patients receiving different antifibrinolytic therapy.23 To adjust for these imbalances, complex statistical methods involving propensity scores was used. Despite the complexity adjustment, aprotinin, in lo ...
1
1

... Do not start SYMBYAX in a patient who is being treated with linezolid or intravenous methylene blue because there is an increased risk of serotonin syndrome. In a patient who requires more urgent treatment of a psychiatric condition, other interventions, including hospitalization, should be consider ...
Product Monograph - Paladin Labs Inc.
Product Monograph - Paladin Labs Inc.

... Tizanidine HCl is an 2-adrenergic agonist (like clonidine) and can produce hypotension. In a single dose study where blood pressure was monitored closely after dosing, two thirds of patients treated with 8 mg of pal-TIZANIDINE had a 20% reduction in either the diastolic or systolic BP. The reductio ...
Chapter 12 Topic: Patterns of Inheritance Reading: Chapter 12
Chapter 12 Topic: Patterns of Inheritance Reading: Chapter 12

... • Allele: A “version” of a gene. Many genes come in two “versions”: dominant and recessive. Some come in multiple “versions,” such as the A, B, and O alleles for blood type. • Phenotype: The outward expression of a gene; that is, the trait itself. • Genotype: The actual genes that code for a particu ...
Factors Associated with the Development of Children Failing Protease Inhibitor-Based
Factors Associated with the Development of Children Failing Protease Inhibitor-Based

... years of age at ART initiation. Before LPV/r safety data became available, ritonavir as single PI (RTV-sPI) was used between 2004 and 2008 in children younger than 6 months of age and during co-treatment with rifampicin-based TB treatment. HIV physicians switched ART regimens using the national prot ...
< 1 ... 222 223 224 225 226 227 228 229 230 ... 1254 >

Pharmacogenomics

Pharmacogenomics (a portmanteau of pharmacology and genomics) is the study of the role of genetics in drug response. It deals with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with drug absorption, distribution, metabolism and elimination, as well as drug receptor target effects. The term pharmacogenomics is often used interchangeably with pharmacogenetics. Although both terms relate to drug response based on genetic influences, pharmacogenetics focuses on single drug-gene interactions, while pharmacogenomics encompasses a more genome-wide association approach, incorporating genomics and epigenetics while dealing with the effects of multiple genes on drug response.Pharmacogenomics aims to develop rational means to optimize drug therapy, with respect to the patients' genotype, to ensure maximum efficacy with minimal adverse effects. Through the utilization of pharmacogenomics, it is hoped that drug treatments can deviate from what is dubbed as the “one-dose-fits-all” approach. It attempts to eliminate the trial-and-error method of prescribing, allowing physicians to take into consideration their patient’s genes, the functionality of these genes, and how this may affect the efficacy of the patient’s current and/or future treatments (and where applicable, provide an explanation for the failure of past treatments). Such approaches promise the advent of ""personalized medicine""; in which drugs and drug combinations are optimized for each individual's unique genetic makeup. Whether used to explain a patient’s response or lack thereof to a treatment, or act as a predictive tool, it hopes to achieve better treatment outcomes, greater efficacy, minimization of the occurrence of drug toxicities and adverse drug reactions (ADRs). For patients who have lack of therapeutic response to a treatment, alternative therapies can be prescribed that would best suit their requirements. In order to provide pharmacogenomic-based recommendations for a given drug, two possible types of input can be used: genotyping or exome or whole genome sequencing. Sequencing provides many more data points, including detection of mutations that prematurely terminate the synthesized protein (early stop codon).
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report